Sublingvální aplikace léčiv. 5

Thesis brings detailed information about sumatriptan succinate, its therapeutic use and dosage forms. In particular, it notes its sublingual administration. Then it provides a summary description of migraine as a pathophysiological unit. The experimental part is focused on the evaluation of in vitro...

Full description

Bibliographic Details
Main Author: Čižinská, Lucie
Other Authors: Doležal, Pavel
Format: Dissertation
Language:Czech
Published: 2012
Online Access:http://www.nusl.cz/ntk/nusl-307108
id ndltd-nusl.cz-oai-invenio.nusl.cz-307108
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-3071082017-06-28T04:16:09Z Sublingvální aplikace léčiv. 5 Sublingual drug delivery. 5 Čižinská, Lucie Doležal, Pavel Vachek, Josef Thesis brings detailed information about sumatriptan succinate, its therapeutic use and dosage forms. In particular, it notes its sublingual administration. Then it provides a summary description of migraine as a pathophysiological unit. The experimental part is focused on the evaluation of in vitro transmucosal permeation of sumatriptan through porcine sublingual membrane. In the first set of experiments sumatriptan succinate was used in three aqueous vehicle in the second part as nanofibre or cast polymer membranes. Acceptor phase was always a phosphate buffer pH 7.4. Determination of sumatriptan permeated was performed by HPLC. For a 3% sumatriptan phosphate buffer pH 7.4 solution and citrate buffer pH 3.4 were pertinent values of fluxes J about 50 [µg/cm2 .h-1 ], about 40 [µg/cm2 .h-1 ], respectively. Very low permeation was found at 1% solution sumatriptan in artificial salivary fluid. The evaluation of sumatriptan fluxes in transmucosal permeation from polymeric membranes brought important results. Very low fluxes provided the cast of polyacrylic acid (PAA) membranes containing 10% of sumatriptan: J = 0.29 ± 0.07 [µg/cm2.h-1]. Surprisingly high values were measured from polyvinylalcohol (PVA) cast membrane containing 10% of sumatriptan J = 6.5 [µg/cm2 .h-1 ] and from the nanofiber PVA... 2012 info:eu-repo/semantics/masterThesis http://www.nusl.cz/ntk/nusl-307108 cze info:eu-repo/semantics/restrictedAccess
collection NDLTD
language Czech
format Dissertation
sources NDLTD
description Thesis brings detailed information about sumatriptan succinate, its therapeutic use and dosage forms. In particular, it notes its sublingual administration. Then it provides a summary description of migraine as a pathophysiological unit. The experimental part is focused on the evaluation of in vitro transmucosal permeation of sumatriptan through porcine sublingual membrane. In the first set of experiments sumatriptan succinate was used in three aqueous vehicle in the second part as nanofibre or cast polymer membranes. Acceptor phase was always a phosphate buffer pH 7.4. Determination of sumatriptan permeated was performed by HPLC. For a 3% sumatriptan phosphate buffer pH 7.4 solution and citrate buffer pH 3.4 were pertinent values of fluxes J about 50 [µg/cm2 .h-1 ], about 40 [µg/cm2 .h-1 ], respectively. Very low permeation was found at 1% solution sumatriptan in artificial salivary fluid. The evaluation of sumatriptan fluxes in transmucosal permeation from polymeric membranes brought important results. Very low fluxes provided the cast of polyacrylic acid (PAA) membranes containing 10% of sumatriptan: J = 0.29 ± 0.07 [µg/cm2.h-1]. Surprisingly high values were measured from polyvinylalcohol (PVA) cast membrane containing 10% of sumatriptan J = 6.5 [µg/cm2 .h-1 ] and from the nanofiber PVA...
author2 Doležal, Pavel
author_facet Doležal, Pavel
Čižinská, Lucie
author Čižinská, Lucie
spellingShingle Čižinská, Lucie
Sublingvální aplikace léčiv. 5
author_sort Čižinská, Lucie
title Sublingvální aplikace léčiv. 5
title_short Sublingvální aplikace léčiv. 5
title_full Sublingvální aplikace léčiv. 5
title_fullStr Sublingvální aplikace léčiv. 5
title_full_unstemmed Sublingvální aplikace léčiv. 5
title_sort sublingvální aplikace léčiv. 5
publishDate 2012
url http://www.nusl.cz/ntk/nusl-307108
work_keys_str_mv AT cizinskalucie sublingvalniaplikaceleciv5
AT cizinskalucie sublingualdrugdelivery5
_version_ 1718473382214762496